The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
The role of targeted therapy (TKI) in the treatment of advanced hepatocellular carcinoma (aHCC) in the era of immunotherapy: Real-world data using AI analytics from an academic medical center.
 
Rachel Su Jen Wong
No Relationships to Disclose
 
Jiaxuan Wu
No Relationships to Disclose
 
Alisha Joan Leen
No Relationships to Disclose
 
Glenn Jin Chong Tey
No Relationships to Disclose
 
Yugarajah Asokumaran
No Relationships to Disclose
 
Gloria Chan
No Relationships to Disclose
 
Chidambaram Siddappan
No Relationships to Disclose
 
Anand Devaprasath Jeyasekharan
Honoraria - AstraZeneca; Janssen; MSD Oncology
Consulting or Advisory Role - Janssen (Inst); MSD Oncology
Research Funding - AstraZeneca; Perkin Elmer
Travel, Accommodations, Expenses - Perkin Elmer
 
Cheng Ean Chee
Consulting or Advisory Role - Bayer; Taiho Pharmaceutical
Travel, Accommodations, Expenses - Taiho Pharmaceutical
 
Wei-Peng Yong
Consulting or Advisory Role - Abbvie/Genentech; Amgen; Bristol-Myers Squibb; Ipsen; Novartis
Speakers' Bureau - Eisai; Lilly; Sanofi/Aventis; Taiho Pharmaceutical
Travel, Accommodations, Expenses - Pfizer
 
Kee Yuan Ngiam
No Relationships to Disclose
 
Raghav Sundar
Honoraria - Bristol-Myers Squibb; Lilly; MSD; Roche; Taiho Pharmaceutical
Consulting or Advisory Role - Bayer; Bristol-Myers Squibb; Eisai; Merck; Taiho Pharmaceutical
Research Funding - MSD; Paxman
Travel, Accommodations, Expenses - AstraZeneca; Eisai; Roche; Taiho Pharmaceutical